Speaker: Wendell Jones, Ph.D.

At Q² Solutions, we have investigated immune expression signatures associated with different immune subtypes and processes, and further categorized these signatures based on their biological origin with emphasis on identifying those signatures having importance and ability to predict patient response-to-therapy and overall survival in multiple tumor indications.

Download our presentation, given at the 2018 PMWC at Duke University, to learn more about the detection of Immune Landscape Signatures for characterization of tumor microenvironment and response to therapy.